How gut bacteria affect infection risk in monoclonal gammopathy patients

Researchers want to understand why some people with monoclonal gammopathy—a blood condition where the body produces abnormal proteins—are more likely to get infections than others. This study will compare the gut bacteria and immune markers in patients with and without infections to see if changes in gut bacteria might explain the difference. By studying these connections, scientists hope to find new ways to prevent or treat infections in these patients.

People with monoclonal gammopathy have a higher risk of developing serious infections, especially if the condition progresses to multiple myeloma. However, doctors don't fully understand why some patients get infections while others don't. This research aims to uncover whether unhealthy changes in gut bacteria play a role in increasing infection risk, which could lead to new prevention strategies.